newsfilter
← Latest News
GlobeNewswire·

Organovo Announces FXR Program

SAN DIEGO, March 21, 2023 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO), a clinical stage biotechnology company that is focused on developing novel human therapies with demonstrated function in high